Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials
  • Large investment of £10m from Oxford Sciences Innovation
  • Further programs include vaccines to boost cancer immunotherapies

Oxford spin out company Vaccitech has launched today with £10m seed investment to develop a universal flu vaccine already showing promise in clinical trials. The company is also developing and testing other vaccines which trigger the immune response needed to prevent or treat a range of serious diseases.

Read more (ISIS Innovation website)